Logo 1.png
Aeterna Zentaris Reports First Quarter 2024 Financial Results
14 mai 2024 18h00 HE | Aeterna Zentaris Inc
Company ended the quarter with $29.5 million in cashDETECT-trial recruitment completed; Company continues to expect the completion of the trial in the second quarter and top-line data in the third...
logo.png
Bright Mountain Media, Inc Announces First Quarter 2024 Financial Results
14 mai 2024 17h00 HE | Bright Mountain Media, Inc.
First quarter revenue increased by $10.9 million to $12.4 million compared to $1.5 million for the first quarter of 2023. First quarter gross margin increased by $2.6 million to $3.1 million compared...
SeaStar_SM_LogoCard.png
SeaStar Medical Reports First Quarter 2024 Financial Results and Provides a Business Update
14 mai 2024 16h05 HE | SeaStar Medical Holding Corporation
DENVER, May 14, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (“SeaStar Medical” or the “Company”), a commercial-stage medical device company developing proprietary...
LOgo.png
Serina Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Highlights
14 mai 2024 16h05 HE | Serina Therapeutics, Inc.
HUNTSVILLE, May 14, 2024 (GLOBE NEWSWIRE) -- Serina Therapeutics (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug delivery...
Logo.png
Harvard Apparatus Regenerative Technology Reports First Quarter 2024 Financial Results and Recent Business Highlights
13 mai 2024 16h45 HE | Harvard Apparatus Regenerative Technology, Inc.
Entered into securities purchase agreements with accredited investors for a $1.5 million private investment in public equity (PIPE) financing. The transaction closed on April 15, 2024.Received $0.5...
Logo.png
Cocrystal Pharma Reports First Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
13 mai 2024 08h00 HE | Cocrystal Pharma, Inc.
Topline single ascending dose (SAD) Phase 1 results of oral CDI-988, the first potential pan-coronavirus-pan-norovirus oral antiviral, expected in the second quarter of 2024 Enrollment completed in...
NO16 NEUROONE LOGO_RGB.png
NeuroOne® to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14
10 mai 2024 14h43 HE | NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., May 10, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving...
Logo.png
Healthier Choices Management Corp. Reports First Quarter 2024 Financial Results
10 mai 2024 08h30 HE | Healthier Choices Management Corp
-First Quarter Record Sales of $15.9 Million, Up 17%, over Q1 2023 -First Quarter Record Gross Profit of $6.1 Million Up 23%, over Q1 2023 HOLLYWOOD, FL, May 10, 2024 ...
logo.png
Parks! America, Inc. to Report Second Quarter Fiscal 2024 Financial Results on May 14, 2024
09 mai 2024 09h00 HE | Parks! America, Inc.
Management to host conference call at 4:30 PM ET PINE MOUNTAIN, Georgia, May 09, 2024 (GLOBE NEWSWIRE) -- Parks! America, Inc. (OTCPink: PRKA), a leading operator of regional safari parks in the...
logo.png
Verano Announces First Quarter 2024 Financial Results
08 mai 2024 06h00 HE | Verano Holdings Corp.
Generated $221 Million in Revenue, Exceeding GuidanceIncreased Gross Profit Margin by Nearly 300 Basis Points Year Over Year CHICAGO, May 08, 2024 (GLOBE NEWSWIRE) -- Verano Holdings Corp....